Effects of amphetamine challenge on local cerebral glucose utilization after chronic dopamine D1 and D2 receptor agonist administration to rats

European Journal of Pharmacology

Volumn 338, Issue 2, 1997, Pages 117-121

  Huang, Yn Ho ^a   Tsai, Shih Jen ^a,b   Huang, Hei Jen ^a   Sim, Cho Boon ^b  

^a NATIONAL YANG MING UNIVERSITY   (Taiwan)

^b TAIPEI VETERANS GENERAL HOSPITAL   (Taiwan)

Author keywords

Amphetamine administration; Chronic; Deoxyglucose; Quinpirole; Sensitization; SKF 38393

Indexed keywords

2,3,4,5 TETRAHYDRO 7,8 DIHYDROXY 1 PHENYL 1H 3 BENZAZEPINE; AMPHETAMINE; DOPAMINE RECEPTOR; DOPAMINE RECEPTOR STIMULATING AGENT; QUINPIROLE;

ANIMAL EXPERIMENT; ARTICLE; BRAIN METABOLISM; DRUG EFFECT; GLUCOSE UTILIZATION; INTRAPERITONEAL DRUG ADMINISTRATION; MALE; NONHUMAN; PRIORITY JOURNAL; RAT; SENSITIZATION;

EID: 0030662624     PISSN: 00142999     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0014-2999(97)81938-3     Document Type: Article

References (22)

1. Clow D.W., Hammer Jr. R.P. Cocaine abstinence following chronic treatment alters cerebral metabolism in dopaminergic reward regions. Neuropsychopharmacology. 4:1991;71-75.
2. Cohen B.M., Wan W. The thalamus as a site of action of antipsychotic drugs. Am. J. Psychiatry. 153:1996;104-106.
3. Drew K.L., Glick S.D. Role of D1 and D2 receptor stimulation in sensitization to amphetamine-induced circling behavior and in expression and extinction of the Pavlovian conditioned response. Psychopharmacology. 101:1990;465-471.
4. Ellinwood E.H. Amphetamine psychosis. I. Description of the individuals and process. J. Nerv. Ment. Dis. 141:1967;273-283.
5. Gerfen C.R., Engber T.M., Mahan L.C., Susel Z., Chase T.N., Monsma Jr. F.J., Sibley D.R. D1 and D2 dopamine receptor-regulated gene expression of striatonigral and striatopallidal neurons. Science. 250:1990;1429-1432.
6. Huang Y.-H., Tsai S.-J., Yu M.-F., Wang Y.-C., Yang Y.-C., Sim C.-B. Dose-dependent effects of chronic amphetamine administration in local cerebral glucose utilization in rat. Neuropsychobiology. 32:1995;149-155.
7. Kelland M.D., Pitts D.K., Freeman A.S., Chiodo L.A. Repeated SKF 38393 and nigrostriatal system neuronal responsiveness: Functional down-regulation is followed by up-regulation after withdrawal. Naunyn Schmiedebergs Arch. Pharmacol. 343:1991;447-457.
8. Malsbury C.W. Facilitation of male rat copulatory behavior by electrical stimulation of the medial preoptic area. Physiol. Behav. 7:1971;797-805.
9. Mattingly B.A., Rowlett J.K., Lovell G. Effects of daily SKF 38393, quinpirole, and SCH 23390 treatments on locomotor activity and subsequent sensitivity to apomorphine. Psychopharmacology. 110:1993;320-326.
10. Porrino L.J., Burns R.S., Crane A.M., Palombo E., Kopin I.J., Sokoloff L. Local cerebral metabolic effects of L-dopa therapy in 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine-induced Parkinsonism in monkeys. Proc. Natl. Acad. Sci. USA. 84:1987;5995-5999.
11. Reith M.E.A., Meisler B.E., Sershen H., Lajtha A. Structural requirements for cocaine congeners to interact with dopamine and serotonin uptake sites in mouse brain and to induce stereotyped behavior. Biochem. Pharmacol. 35:1986;1123-1129.
12. Robinson T.E., Becker J.B. Enduring changes in brain and behavior produced by chronic amphetamine administration: A review and evaluation of animal models of amphetamine psychosis. Brain Res. Rev. 11:1986;157-198.
13. 14C ]deoxyglucose method for the measurement of local cerebral glucose utilization: Theory, procedure and normal values in the conscious and anesthetized albino rat J. Neurochem. 28:1977;897-916.
14. Subramaniam S., Lucki I., McGonigle P. Effects of chronic treatment with selective agonists on the subtypes of dopamine receptors. Brain Res. 571:1992;313-322.
15. Thomas Jr. W.L., Cooke E.S., Hammer Jr. R.P. Cocaine-induced sensitization of metabolic activity in extrapyramidal circuits involves prior dopamine D1-like receptor stimulation. J. Pharmacol. Exp. Ther. 278:1996;347-353.
16. Tirelli E., Jodogne C. Behavioral sensitization and tolerance to the D2 agonist RU 24213: Dissociation between several behavior patterns in mice. Pharmacol. Biochem. Behav. 44:1993;627-632.
17. Trugman J.M., Wooten G.F. Selective D1 and D2 dopamine agonists differentially alter basal ganglia glucose utilization in rats with unilateral 6-hydroxydopamine substantia nigra lesion. J. Neurosci. 7:1987;2927-2935.
18. Ujike H., Onoue R., Akiyama K., Hamaura T., Otsuki S. Effects of selective D-1 and D-2 dopamine antagonists on development of methamphetamine-induced behavioral sensitization. Psychopharmacology. 98:1989;89-92.
19. Vezina P., Stewart J. The effect of dopamine receptor blockade on the development of sensitization to the locomotor activating effects of amphetamine and morphine. Brain Res. 499:1989;108-120.
20. Weiss S.R.B., Post R.M., Pert A., Woodward R., Murman D. Context-dependent cocaine sensitization: Differential effect of haloperidol on development versus expression. Pharmacol. Biochem. Behav. 34:1989;655-661.
21. White F.J., Hu X.-T., Brooderson R.J. Repeated stimulation of dopamine D1 receptors enhances the effects of dopamine receptor agonists. Eur. J. Pharmacol. 191:1990;497-499.
22. Willner P., Papp S., Cheeta S., Muscat R. Environmental influences on behavioural sensitization to the dopamine agonist quinpirole. Behav. Pharmacol. 3:1992;43-50.